α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure–activity relationship study

References

• International Diabetes Federation. IDF Diabetes Atlas, 2015. Available from: http://www.diabetesatlas.org/.
   Google Scholar
• Salsali A, Nathan M. A review of types 1 and 2 diabetes mellitus and their treatment with insulin. Am J Ther 2006;13:349–61.
   PubMedGoogle Scholar
• Wilke T, Boettger B, Berg B, et al. Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: an analysis based on a large sample of 456,586 German T2DM patients. J Diabetes Complicat 2015;29:1015–23.
   PubMed Web of Science ®Google Scholar
• Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J 2012;27:269–73.
   PubMedGoogle Scholar
• Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281–8.
   PubMed Web of Science ®Google Scholar
• Garg SK, Maurer H, Reed K, Selagamsetty R. Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab 2014;16:97–110.
   PubMed Web of Science ®Google Scholar
• Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 1994;43:735–40.
   PubMed Web of Science ®Google Scholar
• Cheng N, Yi WB, Wang QQ, et al. Synthesis and α-glucosidase inhibitory activity of chrysin, diosmetin, apigenin, and luteolin derivatives. Chin Chem Lett 2014;25:1094–8.
   Web of Science ®Google Scholar
• Pereira DF, Cazarolli LH, Lavado C, et al. Effects of flavonoids on α-glucosidase activity: potential targets for glucose homeostasis. Nutrition 2011;27:1161–7.
   PubMed Web of Science ®Google Scholar
• Kawser HM, Abdal DA, Han J, et al. Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids. Int J Mol Sci 2016;17:569–132.
   PubMed Web of Science ®Google Scholar
• Sudhir R, Mohan V. Postprandial hyperglycemia in patients with type 2 diabetes mellitus. Treat Endocrinol 2002;1:105–16.
   PubMedGoogle Scholar
• Leiter LA, Ceriello A, Davidson JA, et al. Postprandial glucose regulation: new data and new implications. Clin Ther 2005;27(Suppl B):S42–S56.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Davidson J, Hanefeld M, et al. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 2006;16:453–6.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Genovese S. Atherogenicity of postprandial hyperglycemia and lipotoxicity. Rev Endocr Metab Disord 2016;17:111–16.
   PubMed Web of Science ®Google Scholar
• Xiao JB, Hogger P. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem 2015;22:23–38.
   PubMed Web of Science ®Google Scholar
• Li YQ, Zhou FC, Gao F, et al. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J Agric Food Chem 2009;57:11463–8.
   PubMed Web of Science ®Google Scholar
• Zeng L, Zhang G, Liao Y, Gong D. Inhibitory mechanism of morin on α-glucosidase and its anti-glycation properties. Food Funct 2016;7:3953–63.
   PubMed Web of Science ®Google Scholar
• Hakamata W, Kurihara M, Okuda H, et al. Design and screening strategies for alpha-glucosidase inhibitors based on enzymological information. Curr Top Med Chem 2009;9:3–12.
   PubMed Web of Science ®Google Scholar
• Priscilla DH, Roy D, Suresh A, et al. Naringenin inhibits α-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem Biol Interact 2014;210:77–85.
   PubMed Web of Science ®Google Scholar
• Joshi SR, Standl E, Tong N, et al. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review. Expert Opin Pharmacother 2015;16:1959–81.
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P. α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci 2012;8:899–906.
   PubMed Web of Science ®Google Scholar
• Lebovitz HE. Alpha-glucosidase inhibitors. Endocrinol Metab Clin North Am 1997;26:539–51.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen Q, Li L, et al. Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: a systematic review and meta-analysis. Sci Rep 2016;6:32649–18.
   PubMed Web of Science ®Google Scholar
• Zeng L, Zhang G, Lin S, Gong D. Inhibitory mechanism of apigenin on α-glucosidase and synergy analysis of flavonoids. J Agric Food Chem 2016;64:6939–49.
   PubMed Web of Science ®Google Scholar
• Silva EL, Lobo JF, Vinther JM, et al. High-resolution α-glucosidase inhibition profiling combined with HPLC-HRMS-SPE-NMR for identification of antidiabetic compounds in Eremanthus crotonoides (Asteraceae). Molecules 2016;21:782.
   Web of Science ®Google Scholar
• Yan J, Zhang G, Pan J, Wang Y. α-Glucosidase inhibition by luteolin: kinetics, interaction and molecular docking. Int J Biol Macromol 2014;64:213–23.
   PubMed Web of Science ®Google Scholar
• Gao H, Nishioka T, Kawabata J, Kasai T. Structure-activity relationships for alpha-glucosidase inhibition of baicalein, 5,6,7-trihydroxyflavone: the effect of A-ring substitution. Biosci Biotechnol Biochem 2004;68:369–75.
   PubMed Web of Science ®Google Scholar
• Na B, Nguyen PH, Zhao BT, et al. Protein tyrosine phosphatase 1B (PTP1B) inhibitory activity and glucosidase inhibitory activity of compounds isolated from Agrimonia pilosa. Pharm Biol 2016;54:474–80.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kwon CS, Son KH. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem 2000;64:2458–61.
   PubMed Web of Science ®Google Scholar
• Kang S, Park JY, Choi H, Kim J. α-Glucosidase inhibitory activities of myricetin in animal models of diabetes mellitus. Food Sci Biotechnol 2015;24:1897–900.
   Web of Science ®Google Scholar
• Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J Nutr Sci Vitaminol 2006;52:149–53.
   PubMed Web of Science ®Google Scholar
• Xu H. Inhibition kinetics of flavonoids on yeast α-glucosidase merged with docking simulations. Protein Pept Lett 2010;17:1270–9.
   PubMed Web of Science ®Google Scholar
• Abdullah NH, Salim F, Ahmad R. Chemical constituents of Malaysian U. cordata var. ferruginea and their in vitro α-glucosidase inhibitory activities. Molecules 2016;21:525.
   PubMed Web of Science ®Google Scholar
• Meng Y, Su A, Yuan S, et al. Evaluation of total flavonoids, myricetin, and quercetin from Hovenia dulcis Thunb. as inhibitors of alpha-amylase and alpha-glucosidase. Plants Food Hum Nutr 2016;71:444–9.
   PubMed Web of Science ®Google Scholar
• Sousa JLC, Proença C, Freitas M, et al. New polyhydroxylated flavon-3-ols and 3-hydroxy-2-styrylchromones: synthesis and ROS/RNS scavenging activities. Eur J Med Chem 2016;119:250–9.
   PubMed Web of Science ®Google Scholar
• Freitas M, Ribeiro D, Tome SM, et al. Synthesis of chlorinated flavonoids with anti-inflammatory and pro-apoptotic activities in human neutrophils. Eur J Med Chem 2014;86:153–64.
   PubMed Web of Science ®Google Scholar
• Ribeiro D, Freitas M, Tome SM, et al. Modulation of human neutrophils’ oxidative burst by flavonoids. Eur J Med Chem 2013;67:280–92.
   PubMed Web of Science ®Google Scholar
• Das D. Biochemistry. 8th ed. Kolkata, India: Academic Publishers, 1993:89–111.
   Google Scholar
• Banerjee S. Inhibition of mackerel (Scomber scombrus) muscle lipoxygenase by green tea polyphenols. Food Res Int 2006;39:486–91.
   Web of Science ®Google Scholar
• Nelson DL, Cox MM. Enzyme kinetics as an approach to understanding mechanism. In: Lehninger principles of biochemistry. 6th ed. New York: W. H. Freeman & Co.; 2014:P200–12.
   Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res 2000;28:235–42.
   PubMed Web of Science ®Google Scholar
• Consortium TU. UniProt: a hub for protein information. Nucleic Acids Res 2015;43:D204–12.
   PubMed Web of Science ®Google Scholar
• Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 2011;27:343–50.
   PubMed Web of Science ®Google Scholar
• Bietz S, Urbaczek S, Schulz B, Rarey M. Protoss: a holistic approach to predict tautomers and protonation states in protein-ligand complexes. J Cheminform 2014;6:1–12.
   PubMed Web of Science ®Google Scholar
• Case DA, Darden TA, Cheatham TE, et al. AMBER 12. University of California, San Francisco; 2012.
   Google Scholar
• Hornak V, Abel R, Okur A, et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006;65:712–25.
   PubMed Web of Science ®Google Scholar
• Kirschner KN, Yongye AB, Tschampel SM, et al. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J Comput Chem 2008;29:622–55.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Miyake H, Kusunoki M, Osaki S. Steric hindrance by 2 amino acid residues determines the substrate specificity of isomaltase from Saccharomyces cerevisiae. J Biosci Bioeng 2011;112:545–50.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455–61.
   PubMed Web of Science ®Google Scholar
• O’Boyle NM, Morley C, Hutchison GR. Pybel: a Python wrapper for the OpenBabel cheminformatics toolkit. Chem Cent J 2008;2:1–7.
   PubMed Web of Science ®Google Scholar
• Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity – a rapid access to atomic charges. Tetrahedron 1980;36:3219–28.
   Web of Science ®Google Scholar
• Eldridge MD, Murray CW, Auton TR, et al. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des 1997;11:425–45.
   PubMed Web of Science ®Google Scholar
• Jones G, Willett P, Glen RC, et al. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727–48.
   PubMed Web of Science ®Google Scholar
• Gao H, Kawabata J. Importance of the B ring and its substitution on the α-glucosidase inhibitory activity of baicalein, 5,6,7-trihydroxyflavone. Biosci Biotechnol Biochem 2004;68:1858–64.
   PubMed Web of Science ®Google Scholar
• Nicolle E, Souard F, Faure P, Boumendjel A. Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship. Curr Med Chem 2011;18:2661–72.
   PubMed Web of Science ®Google Scholar
• Wang QQ, Cheng N, Yi WB, et al. Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives. Bioorg Med Chem 2014;22:1515–21.
   PubMed Web of Science ®Google Scholar
• Kumar V, Kumar S, Rani P. Pharmacophore modeling and 3D-QSAR studies on flavonoids as α-glucosidase inhibitors. Der Pharma Chem 2010;2:324–35.
   Google Scholar
• Gu C, Zhang H, Putri CY, Ng K. Evaluation of α-amylase and α-glucosidase inhibitory activity of flavonoids. Int J Food Nutr Sci 2015;2:1–6.
   Google Scholar
• Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm 2010;2010:1–11.
   Web of Science ®Google Scholar
• Azuma T, Kayano S, Matsumura Y, et al. Antimutagenic and α-glucosidase inhibitory effects of constituents from Kaempferia parviflora. Food Chem 2011;125:471–5.
   Web of Science ®Google Scholar
• Ribeiro D, Freitas M, Lima JL, Fernandes E. Proinflammatory pathways: the modulation by flavonoids. Med Res Rev 2015;35:877–936.
   PubMed Web of Science ®Google Scholar
• Ribeiro D, Freitas M, Tome SM, et al. Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine/chemokine production in human whole blood. Inflammation 2015;38:858–70.
   PubMed Web of Science ®Google Scholar
• Ault A. An introduction to enzyme kinetics. J Chem Educ 1974;51:381–6.
   PubMed Web of Science ®Google Scholar
• Hüttl R, Frank N. Enzymatic kinetic determinations. In: Encyclopedia of analytical chemistry. New York: John Wiley & Sons, Ltd; 2006.
   Google Scholar
• Kakkar T, Pak Y, Mayersohn M. Evaluation of a minimal experimental design for determination of enzyme kinetic parameters and inhibition mechanism. J Pharmacol Exp Ther 2000;293:861–9.
   PubMed Web of Science ®Google Scholar
• Ochs RS. Understanding Enzyme Inhibition. J Chem Educ 2000;77:1453–6.
   Web of Science ®Google Scholar
• Waldrop GL. A qualitative approach to enzyme inhibition. Biochem Mol Biol Educ 2009;37:11–15.
   PubMed Web of Science ®Google Scholar
• Kim M, Lee S, Lee H, et al. Comparative study of the inhibition of α-glucosidase, α-amylase, and cyclomaltodextrin glucanosyltransferase by acarbose, isoacarbose, and acarviosine–glucose. Arch Biochem Biophys 1999;371:277–83.
   PubMed Web of Science ®Google Scholar
• Lopez D, Cherigo L, Spadafora C, et al. Phytochemical composition, antiparasitic and α-glucosidase inhibition activities from Pelliciera rhizophorae. Chem Cent J 2015;9:1–11.
   PubMed Web of Science ®Google Scholar
• Son HU, Lee SH. Comparison of α-glucosidase inhibition by Cudrania tricuspidata according to harvesting time. Biomed Rep 2013;1:624–8.
   PubMedGoogle Scholar